Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Cardiology pioneer Thomas Fogarty dies as 91
Fogarty created many inventions that fundamentally changed cardiac surgical practice. He also received the Presidential Medal of Technology and Innovation from President Barack Obama in 2014.
TAVR remains a viable treatment strategy for cancer patients
Improvements in care have resulted in a growing number of patients who go on to be diagnosed with both cancer and severe aortic stenosis. TAVR appears to be an effective treatment option for those individuals, and it may help them go on to receive life-saving cancer therapies.
Why Shockwave Medical is so excited about the future of intravascular lithotripsy
Nick West, MD, Shockwave Medical's chief medical officer, detailed how the company is continuing to push IVL technologies forward. "We are leading the space ... we have no intention of giving up that position," he said.
FDA confirms new recall after catheter sheath was left in patient’s body
This is a Class I recall, which means the FDA believes these devices could cause a serious injury or death.
W. L. Gore & Associates to acquire medtech company behind foam-based LAAO system
Conformal Medical developed its CLAAS technology to help patients with nonvalvular atrial fibrillation reduce their risk of stroke without the use of anticoagulants. Back in August, the company raised $32 million to help ramp up research on the device.

Cardiac surgeon and innovator Thomas Fogerty, MD, who was awarded the Presidential Medal of Technology.

Cardiology pioneer Thomas Fogarty dies as 91

Fogarty created many inventions that fundamentally changed cardiac surgical practice. He also received the Presidential Medal of Technology and Innovation from President Barack Obama in 2014.

TAVR remains a viable treatment strategy for cancer patients

Improvements in care have resulted in a growing number of patients who go on to be diagnosed with both cancer and severe aortic stenosis. TAVR appears to be an effective treatment option for those individuals, and it may help them go on to receive life-saving cancer therapies.

Nick West, MD, chief medical officer, Shockwave Medical, Johnson and Johnson Meditech, explains how the company is innovating intravascular lithotripsy (IVL) therapy devices and building clinical evidence from trials for its use in a variety of calcified lesions. There are several companies developing IVL therapy, but West says Shockwave will remain the market leader because of its nearly decade long head start in the market, strong clinical evidence and has about a 10% market penetration. #IVKL

Why Shockwave Medical is so excited about the future of intravascular lithotripsy

Nick West, MD, Shockwave Medical's chief medical officer, detailed how the company is continuing to push IVL technologies forward. "We are leading the space ... we have no intention of giving up that position," he said.

FDA confirms new recall after catheter sheath was left in patient’s body

This is a Class I recall, which means the FDA believes these devices could cause a serious injury or death.

M&A mergers and acquisitions business deal

W. L. Gore & Associates to acquire medtech company behind foam-based LAAO system

Conformal Medical developed its CLAAS technology to help patients with nonvalvular atrial fibrillation reduce their risk of stroke without the use of anticoagulants. Back in August, the company raised $32 million to help ramp up research on the device.

FDA approves TMVR system from Edwards Lifesciences for high-risk heart patients

The Sapien M3 transcatheter mitral valve replacement system is implanted using a transseptal approach. The device previously received CE mark approval in 2025.

Cook Medical endovascular grafts recalled due to risk of coating breaking off, entering patient’s bloodstream.

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream

Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer.

FDA recall medical device recall product recall

FDA confirms new recall for Johnson & Johnson heart device over safety concerns

Three patient deaths have been linked to connectivity issues with these devices. The FDA has classified this as a Class I recall.